Efficacy of three different formulations of brimonidine for control of intraocular pressure in primary open-angle glaucoma: A 6-week randomized trial

BACKGROUND: To compare the intraocular pressure (IOP)-lowering efficacy and safety of brimonidine (0.2%), brimonidine purite (0.15%), and brimonidine purite (0.1%) in patients of primary open-angle glaucoma (POAG). MATERIALS AND METHODS: Sixty patients of POAG with IOP >21 mmHg were enrolled into...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhatti, Anubha, Singh, Gursatinder
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5991052/
https://www.ncbi.nlm.nih.gov/pubmed/29930448
http://dx.doi.org/10.4103/ojo.OJO_98_2016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5991052/
https://www.ncbi.nlm.nih.gov/pubmed/29930448
http://dx.doi.org/10.4103/ojo.OJO_98_2016

Ejemplares similares